Navigation Links
Pain Reported by Nearly Half With Type 2 Diabetes
Date:8/14/2012

TUESDAY, Aug. 14 (HealthDay News) -- Nearly 50 percent of patients with type 2 diabetes say they have acute and chronic pain, and about one-quarter suffer from a wide range of symptoms, including nerve damage, fatigue and depression, a new study indicates.

As a result, specialized treatment, called palliative care, that focuses on relieving symptoms and improving quality of life should be a normal part of diabetes management, the researchers suggest.

"Adults living with type 2 diabetes are suffering from incredibly high rates of pain and non-pain symptoms, at levels similar to patients living with cancer," lead study author Dr. Rebecca Sudore, a staff physician at San Francisco VA Medical Center and associate professor of medicine at the University of California, San Francisco, said in a news release that was released jointly by the medical center, the university and Kaiser Permanente.

"Palliative care has already begun to be woven into the care provided to patients with cancer, heart failure and kidney failure," Sudore added. "Our results highlight the need to expand diabetes management to also include the palliative care model."

In conducting the study, researchers from the San Francisco VA Medical Center, the University of California, San Francisco and the Kaiser Permanente Division of Research in Oakland, Calif., examined more than 13,000 adults with type 2 diabetes, aged 30 to 75.

In addition to chronic pain, fatigue and depression, about one in four patients reported neuropathy, which is characterized by tingling or numbness in hands, legs or feet; problems sleeping; and physical or emotional disability, the study revealed. Researchers also found high rates of shortness of breath, nausea and constipation.

Although these symptoms occurred among patients of all ages, the researchers said they were more common toward the end of life.

"The field of diabetes has focused, and rightfully so, on decreasing patients' blood sugar, blood pressure and cholesterol levels in an attempt to prevent complications such as cardiovascular disease, kidney failure, amputations and blindness," Andrew Karter, senior research scientist at Kaiser, said in the joint news release.

"However, our observations provide an important wake-up call for clinicians to not wait until the latest stages of diabetes to focus on these patient-reported outcomes, but rather to consider early palliative care as part of usual chronic disease management," Karter said.

The study was published online Aug. 3 in the Journal of General Internal Medicine.

Nearly 26 million Americans -- or more than 8 percent of the U.S. population -- have diabetes, according to the U.S. Centers for Disease Control and Prevention. Most have the type 2 form of the disease, which is associated with obesity and a sedentary lifestyle. These people don't produce enough insulin or properly use insulin, a hormone needed to convert food into energy. Over time, the damage caused by type 2 diabetes can lead to serious illness and death.

More information

The U.S. National Library of Medicine has more about palliative care.

-- Mary Elizabeth Dallas

SOURCE: San Francisco VA Medical Center, University of California, San Francisco and Kaiser Permanente, news release, Aug. 7, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Survival rates for premature babies in high-level NICUs are better than previously reported
2. Vertebroplasty reportedly provides better pain relief and function
3. Pandemic H1N1 Flu Killed Far More Than Reported: Study
4. Reported increase in older adult fall deaths due to improved coding
5. On-the-job deaths steady in Michigan; Number of burn injuries underreported
6. Diagnostic yield of colonoscopy for melena after nondiagnostic upper endoscopy is lower than previously reported
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Clemson researcher awarded nearly $245,000 to study automation trust and dependence
9. GW School of Nursing receives nearly $1 million grant to diversify nursing workforce
10. Scripps Florida scientists awarded nearly $1.5 million to develop new approaches to treat cancer
11. Einstein receives nearly $5 million to study how Ebola causes infection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pain Reported by Nearly Half With Type 2 Diabetes
(Date:5/21/2017)... ... May 20, 2017 , ... Pot. Reefer. Grass. Mary Jane. No matter what ... its attributes like never before. More than a map, new social marketplace Weedable ... strains, products – and for the first time – each other. A social marketplace ...
(Date:5/21/2017)... ... 2017 , ... Following the tragic and widely publicized death of Rory Staunton, ... that hospitals follow a protocol to quickly identify and treat the condition. , ... steps would have saved Rory or anyone else’s life. , Now, five years ...
(Date:5/19/2017)... (PRWEB) , ... May 19, 2017 , ... ... RawTrition’s BioEnergy in an upcoming episode of Innovations with Ed Begley, Jr., airing ... RawTrition is the distributor of a clean, organic dietary supplement made from naturally ...
(Date:5/19/2017)... ... May 19, 2017 , ... The Miller Agency, a Jacksonville ... and business owners in the region, is embarking on a cooperative charity event ... families. , Multiple sclerosis (MS) is a demyelinating disease that affects the insulation ...
(Date:5/19/2017)... (PRWEB) , ... May 18, 2017 , ... ML Billing, ... of all specialties and sizes and specializes in large group practices, is pleased to ... industry, but it has also set the standard in all aspects of full-service medical ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 10, 2017 CSSi, the global leader in ... research industry, is proud to announce the launch of ... website features both enriched content and a customized layout ... the company,s already well-established position as the top global ... "After many months of hard work, we are delighted ...
(Date:5/9/2017)... 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral ... Intellectual Property Office has granted Oramed a patent ... Exenatide". The patent covers Oramed,s invention of an ... is an incretin hormone that stimulates the secretion ...
(Date:5/8/2017)... 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., has ... ("WRB"), a health care service center company based in ... specializes in relationship management programs for leading pharmaceutical manufacturers ... WRB will join Envoy Health Management, ... for manufacturers, biotech firms, and other service companies. Together, ...
Breaking Medicine Technology: